(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris ISIN Code: FR 0010417345
| Date | Total number of shares | Total number of voting rights |
| 09/30/2024 | 96,501,526 | Total gross of voting rights: 96,501,526 |
| Total net* of voting rights: 96,199,467 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$0.77 |
| Daily Change: | 0.0095 1.25 |
| Daily Volume: | 66,523 |
| Market Cap: | US$74.080M |
November 06, 2024 October 22, 2024 September 23, 2024 | |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
